CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Globus Medical, Inc. - GMED CFD

80.22
4.33%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.24
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023512 %
Charges from full value of position ($-4.47)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023512%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00129 %
Charges from full value of position ($0.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00129%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 83.85
Open 80.66
1-Year Change 49.09%
Day's Range 79.38 - 82.48
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 21, 2025 80.22 1.48 1.88% 78.74 82.63 77.71
Feb 20, 2025 83.85 0.52 0.62% 83.33 84.45 83.00
Feb 19, 2025 83.87 -0.40 -0.47% 84.27 85.35 83.87
Feb 18, 2025 84.68 2.18 2.64% 82.50 84.83 82.50
Feb 14, 2025 83.59 -0.32 -0.38% 83.91 84.64 83.54
Feb 13, 2025 84.01 0.81 0.97% 83.20 84.23 82.98
Feb 12, 2025 83.96 0.68 0.82% 83.28 84.23 82.95
Feb 11, 2025 84.18 -1.90 -2.21% 86.08 86.77 84.16
Feb 10, 2025 87.08 -0.49 -0.56% 87.57 88.03 86.95
Feb 7, 2025 87.52 -0.58 -0.66% 88.10 89.12 86.87
Feb 6, 2025 87.65 -4.30 -4.68% 91.95 92.10 83.77
Feb 5, 2025 91.97 -0.16 -0.17% 92.13 92.91 91.54
Feb 4, 2025 92.11 0.55 0.60% 91.56 93.13 91.47
Feb 3, 2025 92.51 1.35 1.48% 91.16 93.83 90.80
Jan 31, 2025 92.57 -0.54 -0.58% 93.11 94.43 92.39
Jan 30, 2025 92.89 -0.18 -0.19% 93.07 94.77 92.34
Jan 29, 2025 92.44 0.03 0.03% 92.41 93.72 92.18
Jan 28, 2025 92.85 1.75 1.92% 91.10 92.89 90.55
Jan 27, 2025 91.86 0.26 0.28% 91.60 92.57 90.68
Jan 24, 2025 92.75 1.47 1.61% 91.28 92.97 91.05

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Globus Medical, Inc. Company profile

About Globus Medical Inc

Globus Medical, Inc. is a medical device company. The Company is primarily focused on implants that promote healing in patients with musculoskeletal disorders. The Company group its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery, which are computer-assisted intelligent systems designed to improve a surgeon’s capabilities, and ultimately improve patient care and reduce radiation exposure for all involved. Its INR solutions include the ExcelsiusGPS platform, which is a robotic guidance and navigation system that supports minimally invasive and open procedures with screw and interbody spacer placement applications.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Globus Medical Inc revenues increased 21% to $958.1M. Net income increased 46% to $149.2M. Revenues reflect Musculoskeletal Solutions products segment increase of 17% to $876.8M, Enabling Technologies products segment increase of 100% to $81.3M, United States segment increase of 23% to $819.6M, International segment increase of 11% to $138.5M.

Equity composition

Cls A Common stock $.001 Par 8/12, 500M auth., 62,503,441 issd., Insiders own approx. 86.70%. Cls B Common Stock 275M auth., 27,885,000 issd.

Industry: Medical Equipment, Supplies & Distribution (NEC)

2560 General Armistead Ave
AUDUBON
PENNSYLVANIA 19403
US

People also watch

ETH/USD

2,779.27 Price
+5.290% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,936.56 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0149%
Short position overnight fee 0.0067%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,594.40 Price
-2.120% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

96,674.75 Price
+1.390% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading